Investigation Report on China's Pancreatic Kininogenase Market, 2018-2022

Publisher Name :
Date: 01-Jan-2019
No. of pages: 30

Description

The incidence of and the death rate from cardiovascular and cerebrovascular diseases are increasing in China with the development of economy, the change of lifestyle and the aging of the population. It is estimated that nearly 300 million people in China are suffering from cardiovascular and cerebrovascular diseases. The number of patients with stroke, coronary heart disease, heart failure, pulmonary heart disease, rheumatic heart disease, congenital heart disease and hypertension amounts to 13 million, 11 million, 4.5 million, 5 million, 2.5 million, 2 million and 270 million respectively. With a higher death rate than tumors and other diseases, cardiovascular diseases account for more than 40% disease deaths in China. In particular, rural areas have seen higher death rate from cardiovascular diseases than urban areas in recent years. And the costs of hospitalization resulting from cardiovascular and cerebrovascular diseases are also increasing sharply.

Pancreatic Kininogenase can be used to treat cardiovascular and cerebrovascular diseases such as primary hypertension, arteriosclerosis, coronary atherosclerotic heart disease, cerebral arteriosclerosis, cerebral thrombosis, retinal vascular disorder and peripheral vascular disease. Recent studies have found that Pancreatic Kininogenase can also be used to prevent diabetic microangiopathy and early diabetic nephropathy by reducing the discharge of urinary albumin. In addition, Pancreatic Kininogenase can increase the activity and production of sperms, and thus has certain curative effect on male infertility, according to domestic clinical data.

In 1999, Changzhou Qianhong Bio-pharma Co., Ltd.'s Pancreatic Kininogenase was first launched in China, followed by the counterparts of Chengdu Tongde Pharmaceutical Co., Ltd., Henan Livu Pharmacy Co., Ltd., Shanghai Livzon Pharmaceutical Co., Ltd., etc. At present, there are seven Pancreatic Kininogenase manufacturers in China. Changzhou Qianhong Bio-pharma Co., Ltd.'s Pancreatic Kininogenase (trade name: Yikai) takes up about 90% market share by sales value.

It is expected that as the incidence of cardiovascular and cerebrovascular diseases continues to increase, China's Pancreatic Kininogenase market will still have some growth potential in the next few years.

Topics Covered:


  • Situation of cardiovascular and cerebrovascular diseases in China

  • Status of China's Pancreatic Kininogenase market

  • Competition on China's Pancreatic Kininogenase market

  • Factors influencing the development of China's Pancreatic Kininogenase market

  • Prospect of China's Pancreatic Kininogenase market

Investigation Report on China's Pancreatic Kininogenase Market, 2018-2022

Table of Contents

1 Relevant Concepts of Pancreatic Kininogenase
1.1 Indications for Pancreatic Kininogenase
1.2 Development of Pancreatic Kininogenase in China
1.3 Government Approval of Pancreatic Kininogenase in China

2 Sales of Pancreatic Kininogenase in China, 2013-2017
2.1 Sales Value of Pancreatic Kininogenase
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Pancreatic Kininogenase
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Pancreatic Kininogenase by Dosage Form in China, 2013-2017
2.3.1 Pancreatic Kininogenase Injections
2.3.2 Pancreatic Kininogenase Tablets

3 Analysis on Major Pancreatic Kininogenase Manufacturers in China, 2013-2017
3.1 Analysis on Market Share of Major Pancreatic Kininogenase Manufacturers in China
3.1.1 Market Share by Sales Value
3.1.2 Market Share by Sales Volume
3.2 Shanghai Livzon Pharmaceutical Co., Ltd.
3.2.1 Enterprise Profile
3.2.2 Sales of Shanghai Livzon Pharmaceutical Co., Ltd.'s Pancreatic Kininogenase in China
3.3 Sichuan Shunsheng Pharmaceutical Co., Ltd.
3.3.1 Enterprise Profile
3.3.2 Sales of Sichuan Shunsheng Pharmaceutical Co., Ltd.'s Pancreatic Kininogenase in China
3.4 Changzhou Qianhong Bio-pharma Co., Ltd.
3.5 Chengdu Tongde Pharmaceutical Co., Ltd.
3.6 Henan Livu Pharmacy Co., Ltd.

4 Prices of Pancreatic Kininogenase in China, 2017-2018
4.1 Shanghai Livzon Pharmaceutical Co., Ltd. (Guangle)
4.2 Sichuan Shunsheng Pharmaceutical Co., Ltd. (Dashun)
4.3 Changzhou Qianhong Bio-pharma Co., Ltd. (Yikai)
4.4 Chengdu Tongde Pharmaceutical Co., Ltd. (Tongde)
4.5 Henan Livu Pharmaceutical Co., Ltd. (Duomeile)

5 Prospect of China's Pancreatic Kininogenase Market, 2018-2022
5.1 Factors Influencing Development Pancreatic Kininogenase Market
5.2 Forecast on Market Size
5.3 Forecast on Market Trend

List of Charts

Chart Government Approval of Pancreatic Kininogenase in China
Chart Sales Value of Pancreatic Kininogenase in China, 2013-2017
Chart Sales Value of Pancreatic Kininogenase in Parts of China, 2013-2017
Chart Sales Volume of Pancreatic Kininogenase in China, 2013-2017
Chart Sales Volume of Pancreatic Kininogenase in Parts of China, 2013-2017
Chart Sales Value of Pancreatic Kininogenase Injections in China, 2013-2017
Chart Sales Volume of Pancreatic Kininogenase Injections in China, 2013-2017
Chart Sales Value of Pancreatic Kininogenase Tablets in China, 2013-2017
Chart Market Share of Top 5 Pancreatic Kininogenase Manufacturers by Sales Value in China, 2013-2017
Chart Market Share of Top 5 Pancreatic Kininogenase Manufacturers by Sales Volume in China, 2013-2017
Chart Sales Value of Shanghai Livzon Pharmaceutical Co., Ltd.'s Pancreatic Kininogenase, 2013-2017
Chart Sales Volume of Shanghai Livzon Pharmaceutical Co., Ltd.'s Pancreatic Kininogenase, 2013-2017
Chart Sales Value of Sichuan Shunsheng Pharmaceutical Co., Ltd.'s Pancreatic Kininogenase, 2013-2017
Chart Sales Value of Changzhou Qianhong Bio-pharma Co., Ltd.'s Pancreatic Kininogenase, 2013-2017
Chart Sales Value of Chengdu Tongde Pharmaceutical Co., Ltd.'s Pancreatic Kininogenase, 2013-2017
Chart Prices of Shanghai Livzon Pharmaceutical Co., Ltd.'s Pancreatic Kininogenase in Parts of China, 2017-2018
Chart Prices of Sichuan Shunsheng Pharmaceutical Co., Ltd.'s Pancreatic Kininogenase in Parts of China, 2017-2018
Chart Prices of Changzhou Qianhong Bio-pharma Co., Ltd.'s Pancreatic Kininogenase in Parts of China, 2017-2018
Chart Forecast on Sales Value of Pancreatic Kininogenase in China, 2018-2022

  • Global Cancer Immunomodulator Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......
  • Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......
  • Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......
  • Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125
    According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......
  • Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112
    This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......
  • Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......
  • T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85
    CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......
  • Global Kaposi Sarcoma Market Status and Outlook 2023-2028
    Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107
    Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......
  • Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118
    Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs